Aparicio-Blanco, Juan <br/><br/>
Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy.  [electronic resource] 

 -  International journal of pharmaceutics  May 2020 
 - 119283 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1873-3476 
<br/><br/><label>Standard No.: </label>10.1016/j.ijpharm.2020.119283  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Blood-Brain Barrier--drug effects<br/>Brain--drug effects<br/>Brain Neoplasms--drug therapy<br/>Clinical Trials as Topic--methods<br/>Drug Delivery Systems--methods<br/>Glioblastoma--drug therapy<br/>Humans<br/>Nanomedicine--methods<br/>Treatment Outcome